These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6460414)

  • 1. [Different reactivity of UK- and SK-activated plasmin against two fluorogenic substrates for plasmin (author's transl)].
    Suzuki K; Nishioka J; Hashimoto S
    Nihon Ketsueki Gakkai Zasshi; 1981 May; 44(3):690-8. PubMed ID: 6460414
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enzymatic fibrinolytic agents].
    Jamet M; Granthil C; Levy G
    Ann Anesthesiol Fr; 1978; 19(8):693-6. PubMed ID: 31112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New fluorogenic peptide substrates for plasmin.
    Kato H; Adachi N; Ohno Y; Iwanaga S; Takada K; Sakakibara S
    J Biochem; 1980 Jul; 88(1):183-90. PubMed ID: 6447693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Index of fibrinolysis with new fibrin plate (author's transl)].
    Hishikawa Y; Sugie I
    Nihon Seirigaku Zasshi; 1977; 39(1):1-11. PubMed ID: 140239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Compared activation of kinin system by streptokinase and urokinase "in vitro" and during thrombolytic treatments (author's transl)].
    Migne J; Vedrine Y; Conard J; Samama M
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():42-7. PubMed ID: 149942
    [No Abstract]   [Full Text] [Related]  

  • 6. The inhibitory effect of plasma inhibitor on plasmin activated with streptokinase or urokinase.
    Sumi H; Takada Y; Takada A
    Nihon Seirigaku Zasshi; 1977; 39(5):112-4. PubMed ID: 72149
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of action of fibrinolytic enzymes in vivo.
    Ambrus JL; Weber FJ; Ambrus CM
    J Med; 1979; 10(1-2):99-119. PubMed ID: 158624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of coagulation on the activation of plasminogen by streptokinase and urokinase.
    Takada A; Urano T; Takada Y
    Thromb Haemost; 1979 Oct; 42(3):901-8. PubMed ID: 505405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of plasmin, microplasmin, and streptokinase-plasmin complex for the in vitro degradation of fibronectin and laminin- implications for vitreoretinal surgery.
    Hermel M; Dailey W; Hartzer MK
    Curr Eye Res; 2010 May; 35(5):419-24. PubMed ID: 20450255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activation of two isozymes of glu-plasminogen (I and II) by urokinase and streptokinase.
    Takada A; Takada Y
    Thromb Res; 1983 Jun; 30(6):633-42. PubMed ID: 6351345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the effect of plasminogen activator on the interaction between alpha 2-macroglobulin and plasmin.
    Toki N; Takasugi S; Sumi H; Yamura T
    Thromb Haemost; 1978 Oct; 40(2):377-86. PubMed ID: 83685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of arterial thrombosis successfully treated with a large dosage of urokinase--study on urokinase administration with special reference to alpha2-plasmin inhibitor (author's transl)].
    Hayashi S; Yamada K
    Rinsho Ketsueki; 1979 Apr; 20(4):400-9. PubMed ID: 156270
    [No Abstract]   [Full Text] [Related]  

  • 14. [Separation of plasmin and plasminogen-activator from SK-activatable fraction B of human plasma (author's transl)].
    Yamamoto J
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):107-20. PubMed ID: 4277925
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urokinase. Biochemical therapeutical and therapeutical data (author's transl)].
    Kher A
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():54-69. PubMed ID: 64958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN; Gurewich V
    J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urokinase inhibitor in human tonsils (author's transl)].
    Sasaki Y; Horiuchi K
    Josai Shika Daigaku Kiyo; 1974; (3):221-5. PubMed ID: 4283571
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on thrombolytic therapy for venous thrombosis in the extremities--dynamics of plasmin inhibitor and FDP following administration of urokinase (author's transl)].
    Takeuchi S; Shiba T
    Nihon Geka Hokan; 1979 May; 48(3):354-61. PubMed ID: 157109
    [No Abstract]   [Full Text] [Related]  

  • 19. [In vitro study of a human plasmin (CY 218) and its association with urokinase (author's transl)].
    Brochier M; Griguer P
    Rev Med Brux; 1981 Mar; 2(3):167-74. PubMed ID: 6453415
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on activator formation in human plasma with streptokinase. III. Investigation of activator kinetics in undiluted plasma in terms of urokinase equivalents.
    Martin M
    Thromb Haemost; 1976 Dec; 36(3):566-81. PubMed ID: 138962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.